Epstein-Barr virus infection induces an increase of T regulatory type 1 cells in Hodgkin lymphoma patients

British Journal of Haematology

Volumn 166, Issue 6, 2014, Pages 875-890

  Morales, Olivier ^a   Mrizak, Dhafer ^a   François, Violaine ^a,b   Mustapha, Rami ^a   Miroux, Céline ^a   Depil, Stéphane ^a,c,d   Decouvelaere, Anne Valérie ^e,f   Lionne Huyghe, Pauline ^c,g   Auriault, Claude ^a,h   de Launoit, Yvan ^a   Pancré, Véronique ^a   Delhem, Nadira ^a  

^a UNIV LILLE   (France)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e Service d'Anatomo pathologie Pôle Biologie Pathologie Eurasanté   (France)

^f CENTRE LÉON BÉRARD   (France)

^g Service Hématologie Clinique Centre hospitalier Besnier   (France)

^h INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Chemokines; Epstein Barr Virus; Hodgkin lymphoma; IL10; Tr1

Indexed keywords

ALPHA2 INTEGRIN; CD18 ANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CXCL9 CHEMOKINE; INTERLEUKIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; RANTES; THYMUS AND ACTIVATION REGULATED CHEMOKINE; VIRUS PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CARCINOGENESIS; CELL TRANSPORT; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; FLOW CYTOMETRY; FROZEN SECTION; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; ITGA2 GENE; ITGB2 GENE; LAG3 GENE; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SCHOOL CHILD; TH2 CELL; TRANSCRIPTOMICS; TUMOR CELL; TUMOR ESCAPE; TUMOR MICROENVIRONMENT; UPREGULATION; YOUNG ADULT;

CHEMOKINES; EPSTEIN-BARR VIRUS; HODGKIN LYMPHOMA; IL10; TR1;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CHEMOKINES; CHILD; CYTOKINES; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; T-LYMPHOCYTES, REGULATORY; TH2 CELLS; UP-REGULATION; YOUNG ADULT;

EID: 84907598985     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12980     Document Type: Article

References (54)

1. Alvaro, T., Lejeune, M., Salvado, M.T., Bosch, R., Garcia, J.F., Jaen, J., Banham, A.H., Roncador, G., Montalban, C. & Piris, M.A. (2005) Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clinical Cancer Research, 11, 1467-1473.
2. Baecher-Allan, C.M. & Hafler, D.A. (2005) Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+CD25+ T cells. Clinical Immunology, 117, 192; discussion 193.
3. Barath, S., Aleksza, M., Keresztes, K., Toth, J., Sipka, S., Szegedi, G. & Illes, A. (2006) Immunoregulatory T cells in the peripheral blood of patients with Hodgkin's lymphoma. Acta Haematologica, 116, 181-185.
4. Baumforth, K.R., Birgersdotter, A., Reynolds, G.M., Wei, W., Kapatai, G., Flavell, J.R., Kalk, E., Piper, K., Lee, S., Machado, L., Hadley, K., Sundblad, A., Sjoberg, J., Bjorkholm, M., Porwit, A.A., Yap, L.F., Teo, S., Grundy, R.G., Young, L.S., Ernberg, I., Woodman, C.B. & Murray, P.G. (2008) Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates up-regulation of CCL20 and the migration of regulatory T cells. American Journal of Pathology, 173, 195-204.
5. Birebent, B., Lorho, R., Lechartier, H., de Guibert, S., Alizadeh, M., Vu, N., Beauplet, A., Robillard, N. & Semana, G. (2004) Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA-4 expression. European Journal of Immunology, 34, 3485-3496.
6. Campbell, D.J. & Koch, M.A. (2011) Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nature Reviews Immunology, 11, 119-130.
7. Carpentier, A., Conti, F., Carriere, M., Aoudjehane, L., Miroux, C., Morales, O., Calmus, Y., Groux, H., Auriault, C., Pancre, V., Delhem, N. & Podevin, P. (2009) Analysis of gene transcription in sera during chronic hepatitis C infection. Journal of Medical Virology, 81, 473-480.
8. Chapman, A.L., Rickinson, A.B., Thomas, W.A., Jarrett, R.F., Crocker, J. & Lee, S.P. (2001) Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumour site of Hodgkin's disease patients: implications for a T-cell-based therapy. Cancer Research, 61, 6219-6226.
9. Chen, B., Zhang, D., Zhou, J., Li, Q., Zhou, L., Li, S.M., Zhu, L., Chou, K.Y., Zhou, L., Tao, L. & Lu, L.M. (2013) High CCR6/CCR7 expression and Foxp3+ Treg cell number are positively related to the progression of laryngeal squamous cell carcinoma. Oncology Reports, 30, 1380-1390.
10. Curiel, T.J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J.R., Zhang, L., Burow, M., Zhu, Y., Wei, S., Kryczek, I., Daniel, B., Gordon, A., Myers, L., Lackner, A., Disis, M.L., Knutson, K.L., Chen, L. & Zou, W. (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature Medicine, 10, 942-949.
11. Deane, J.A., Abeynaike, L.D., Norman, M.U., Wee, J.L., Kitching, A.R., Kubes, P. & Hickey, M.J. (2012) Endogenous regulatory T cells adhere in inflamed dermal vessels via ICAM-1: association with regulation of effector leukocyte adhesion. The Journal of Immunology, 188, 2179-2188.
12. Depil, S., Morales, O. & Auriault, C. (2004) Hodgkin's disease and Epstein-Barr virus. Annales De Biologie Clinique, 62, 639-648.
13. Ephrem, A., Epstein, A.L., Stephens, G.L., Thornton, A.M., Glass, D. & Shevach, E.M. (2013) Modulation of Treg cells/T effector function by GITR signaling is context-dependent. European Journal of Immunology, 43, 2421-2429.
14. Flores-Borja, F., Jury, E.C., Mauri, C. & Ehrenstein, M.R. (2008) Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proceedings of the National Academy of Sciences of the United States of America, 105, 19396-19401.
15. Fontenot, J.D., Gavin, M.A. & Rudensky, A.Y. (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nature Immunology, 4, 330-336.
16. Gagliani, N., Magnani, C.F., Huber, S., Gianolini, M.E., Pala, M., Licona-Limon, P., Guo, B., Herbert, D.R., Bulfone, A., Trentini, F., Di Serio, C., Bacchetta, R., Andreani, M., Brockmann, L., Gregori, S., Flavell, R.A. & Roncarolo, M.G. (2013) Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nature Medicine, 19, 739-746.
17. Gaiolla, R.D., Domingues, M.A., Niero-Melo, L. & de Oliveira, D.E. (2011) Serum levels of interleukins 6, 10, and 13 before and after treatment of classic Hodgkin lymphoma. Archives of Pathology and Laboratory Medicine, 135, 483-489.
18. Gandhi, M.K., Lambley, E., Duraiswamy, J., Dua, U., Smith, C., Elliott, S., Gill, D., Marlton, P., Seymour, J. & Khanna, R. (2006) Expression of LAG-3 by tumour-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients. Blood, 108, 2280-2289.
19. Greaves, P., Clear, A., Owen, A., Iqbal, S., Lee, A., Matthews, J., Wilson, A., Calaminici, M. & Gribben, J.G. (2013) Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells. Blood, 122, 2856-2863.
20. Groux, H., Bigler, M., de Vries, J.E. & Roncarolo, M.G. (1996) Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. Journal of Experimental Medicine, 184, 19-29.
21. Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J.E. & Roncarolo, M.G. (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature, 389, 737-742.
22. Herling, M., Rassidakis, G.Z., Vassilakopoulos, T.P., Medeiros, L.J. & Sarris, A.H. (2006) Impact of LMP-1 expression on clinical outcome in age-defined subgroups of patients with classical Hodgkin lymphoma. Blood, 107, 1240; author reply 1241.
23. Hohaus, S., Giachelia, M., Massini, G., Vannata, B., Criscuolo, M., Martini, M., D'Alo, F., Voso, M.T., Larocca, L.M. & Leone, G. (2009) Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma. Leukemia Research, 33, 1352-1356.
24. Huang, C.T., Workman, C.J., Flies, D., Pan, X., Marson, A.L., Zhou, G., Hipkiss, E.L., Ravi, S., Kowalski, J., Levitsky, H.I., Powell, J.D., Pardoll, D.M., Drake, C.G. & Vignali, D.A. (2004) Role of LAG-3 in regulatory T cells. Immunity, 21, 503-513.
25. Iellem, A., Mariani, M., Lang, R., Recalde, H., Panina-Bordignon, P., Sinigaglia, F. & D'Ambrosio, D. (2001) Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. Journal of Experimental Medicine, 194, 847-853.
26. Jarrett, R.F., Stark, G.L., White, J., Angus, B., Alexander, F.E., Krajewski, A.S., Freeland, J., Taylor, G.M. & Taylor, P.R. (2005) Impact of tumour Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study. Blood, 106, 2444-2451.
27. Keegan, T.H., Glaser, S.L., Clarke, C.A., Gulley, M.L., Craig, F.E., Digiuseppe, J.A., Dorfman, R.F., Mann, R.B. & Ambinder, R.F. (2005) Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study. Journal of Clinical Oncology, 23, 7604-7613.
28. Kim, J.M. & Rudensky, A. (2006) The role of the transcription factor Foxp3 in the development of regulatory T cells. Immunological Reviews, 212, 86-98.
29. Kwon, J.M., Park, Y.H., Kang, J.H., Kim, K., Ko, Y.H., Ryoo, B.Y., Lee, S.S., Lee, S.I., Koo, H.H. & Kim, W.S. (2006) The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma. Annals of Hematology, 85, 463-468.
30. Li, J., Qian, C.N. & Zeng, Y.X. (2009) Regulatory T cells and EBV associated malignancies. International Immunopharmacology, 9, 590-592.
31. Liu, W., Ren, H.Y., Dong, Y.J., Wang, L.H., Yin, Y., Li, Y., Qiu, Z.X., Cen, X.N. & Shi, Y.J. (2012) Bortezomib regulates the chemotactic characteristics of T cells through downregulation of CXCR3/CXCL9 expression and induction of apoptosis. International Journal of Hematology, 96, 764-772.
32. Livak, K.J. & Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25, 402-408.
33. Maganto-Garcia, E., Tarrio, M.L., Grabie, N., Bu, D.X. & Lichtman, A.H. (2011) Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia. Circulation, 124, 185-195.
34. Mandapathil, M., Szczepanski, M., Harasymczuk, M., Ren, J., Cheng, D., Jackson, E.K., Gorelik, E., Johnson, J., Lang, S. & Whiteside, T.L. (2012) CD26 expression and adenosine deaminase activity in regulatory T cells (Treg) and CD4(+) T effector cells in patients with head and neck squamous cell carcinoma. Oncoimmunology, 1, 659-669.
35. Marshall, N.A., Vickers, M.A. & Barker, R.N. (2003) Regulatory T cells secreting IL-10 dominate the immune response to EBV latent membrane protein 1. The Journal of Immunology, 170, 6183-6189.
36. Marshall, N.A., Christie, L.E., Munro, L.R., Culligan, D.J., Johnston, P.W., Barker, R.N. & Vickers, M.A. (2004) Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. Blood, 103, 1755-1762.
37. McGuirk, P. & Mills, K.H. (2002) Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Trends in Immunology, 23, 450-455.
38. Menetrier-Caux, C., Faget, J., Biota, C., Gobert, M., Blay, J.Y. & Caux, C. (2012) Innate immune recognition of breast tumour cells mediates CCL22 secretion favoring Treg recruitment within tumour environment. Oncoimmunology, 1, 759-761.
39. Morales, O., Depil, S., Mrizak, D., Martin, N., Ndour, P.A., Dufosse, F., Miroux, C., Coll, J., de Launoit, Y., Auriault, C., Pancre, V. & Delhem, N. (2012) EBV Latency II-derived peptides induce a specific CD4+ cytotoxic T-cell activity and not a CD4+ regulatory T-cell response. Journal of Immunotherapy, 35, 254-266.
40. Pere, H., Montier, Y., Bayry, J., Quintin-Colonna, F., Merillon, N., Dransart, E., Badoual, C., Gey, A., Ravel, P., Marcheteau, E., Batteux, F., Sandoval, F., Adotevi, O., Chiu, C., Garcia, S., Tanchot, C., Lone, Y.C., Ferreira, L.C., Nelson, B.H., Hanahan, D., Fridman, W.H., Johannes, L. & Tartour, E. (2011) A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumour immunity against self antigens. Blood, 118, 4853-4862.
41. Poppema, S., Potters, M., Emmens, R., Visser, L. & van den Berg, A. (1999) Immune reactions in classical Hodgkin's lymphoma. Seminars in Hematology, 36, 253-259.
42. Rahmoun, M., Foussat, A., Groux, H., Pene, J., Yssel, H. & Chanez, P. (2006) Enhanced frequency of CD18- and CD49b-expressing T cells in peripheral blood of asthmatic patients correlates with disease severity. International Archives of Allergy and Immunology, 140, 139-149.
43. Skinnider, B.F. & Mak, T.W. (2002) The role of cytokines in classical Hodgkin lymphoma. Blood, 99, 4283-4297.
44. Slivnick, D.J., Nawrocki, J.F. & Fisher, R.I. (1989) Immunology and cellular biology of Hodgkin's disease. Hematology/Oncology Clinics of North America, 3, 205-220.
45. Slivnick, D.J., Ellis, T.M., Nawrocki, J.F. & Fisher, R.I. (1990) The impact of Hodgkin's disease on the immune system. Seminars in Oncology, 17, 673-682.
46. Suri-Payer, E., Amar, A.Z., Thornton, A.M. & Shevach, E.M. (1998) CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. The Journal of Immunology, 160, 1212-1218.
47. Svensson, H., Olofsson, V., Lundin, S., Yakkala, C., Bjorck, S., Borjesson, L., Gustavsson, B. & Quiding-Jarbrink, M. (2012) Accumulation of CCR4(+)CTLA-4 FOXP3(+)CD25(hi) regulatory T cells in colon adenocarcinomas correlate to reduced activation of conventional T cells. PLoS ONE, 7, e30695.
48. Voo, K.S., Peng, G., Guo, Z., Fu, T., Li, Y., Frappier, L. & Wang, R.F. (2005) Functional characterization of EBV-encoded nuclear antigen 1-specific CD4+ helper and regulatory T cells elicited by in vitro peptide stimulation. Cancer Research, 65, 1577-1586.
49. Wan, Y.Y. & Flavell, R.A. (2005) Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proceedings of the National Academy of Sciences of the United States of America, 102, 5126-5131.
50. Wei, W.Z., Morris, G.P. & Kong, Y.C. (2004) Anti-tumour immunity and autoimmunity: a balancing act of regulatory T cells. Cancer Immunology, Immunotherapy, 53, 73-78.
51. Wilson, A.D., Hopkins, J.C. & Morgan, A.J. (2001) In vitro cytokine production and growth inhibition of lymphoblastoid cell lines by CD4+ T cells from Epstein-Barr virus (EBV) seropositive donors. Clinical and Experimental Immunology, 126, 101-110.
52. Wood, K.J., Feng, G., Wei, B., Sawitzki, B. & Bushell, A.R. (2007) Interferon gamma: friend or foe? Transplantation, 84, S4-S5.
53. Young, L.S. & Rickinson, A.B. (2004) Epstein-Barr virus: 40 years on. Nature Reviews Cancer, 4, 757-768.
54. Zitvogel, L., Tanchot, C., Granier, C. & Tartour, E. (2013) Following up tumour-specific regulatory T cells in cancer patients. Oncoimmunology, 2, e25444.